Lv4
420 积分 2025-08-04 加入
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer
9小时前
求助中
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer
10小时前
已完结
p65-NFκB synergizes with Notch to activate transcription by triggering cytoplasmic translocation of the nuclear receptor corepressor N-CoR
1个月前
已完结
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
1个月前
已完结
Overall Survival with Amivantamab–Lazertinib in EGFR-Mutated Advanced NSCLC
1个月前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
7个月前
已完结
Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non-small-cell lung cancer and EGFR mutation
8个月前
已完结
Precision Oncology: 2025 in Review
8个月前
已完结
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
11个月前
已完结
Sepsis and Septic Shock
1年前
已完结
皖公网安备34019202002308
